Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis
Matthew R Evans1, Agustín Escalante, Daniel F Battafarano
1Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
Insights
Acute coronary syndromes (ACS) are strongly linked to atherosclerosis in rheumatoid arthritis (RA) patients. Identifying carotid plaque and risk factors like diabetes can help predict ACS events in this population.
Area of Science:
- Rheumatology
- Cardiology
- Vascular Medicine
Background:
- Rheumatoid arthritis (RA) is an autoimmune disease associated with increased cardiovascular risk.
- The specific contribution of atherosclerosis to acute coronary syndromes (ACS) in RA patients requires detailed quantification.
Purpose of the Study:
- To determine the association between carotid atherosclerosis and the occurrence of ACS in patients with rheumatoid arthritis.
- To quantify the extent to which atherosclerosis contributes to ACS events in an RA cohort.
Main Methods:
- Prospective cohort study involving 636 RA patients followed for 3,402 person-years.
- Measurement of carotid atherosclerosis via high-resolution ultrasound.
- Cox proportional hazards models used to assess the association between ACS and atherosclerosis, adjusting for covariates.
Main Results:
- Atherosclerosis was significantly associated with ACS in RA patients.
- The incidence of ACS increased with the presence and extent of carotid plaque (1.1 events/100 patient-years without plaque, 4.3 events/100 patient-years with bilateral plaque).
- Independent predictors of ACS included male sex, diabetes mellitus, and cumulative glucocorticoid dose (≥ 20 gm).
Conclusions:
- Atherosclerosis is a significant contributor to ACS in patients with RA.
- RA patients with carotid plaque, multiple cardiovascular risk factors (diabetes, hypertension), numerous swollen joints, high cumulative glucocorticoid dose, or male sex are at elevated risk for ACS.
Objective:
The role of atherosclerosis in the acute coronary syndromes (ACS) that occur in patients with rheumatoid arthritis (RA) has not been quantified in detail. We undertook this study to determine the extent to which ACS are associated with carotid atherosclerosis in RA.
Methods:
We prospectively ascertained ACS, defined as myocardial infarction, unstable angina, cardiac arrest, or death due to ischemic heart disease, in an RA cohort. We measured carotid atherosclerosis using high-resolution ultrasound. We used Cox proportional hazards models to estimate the association between ACS and atherosclerosis, adjusting for demographic features, cardiovascular (CV) risk factors, and RA manifestations.
Results:
We performed carotid ultrasound on 636 patients whom we followed up for 3,402 person-years. During this time, 84 patients experienced 121 new or recurrent ACS events, a rate of 3.5 ACS events per 100 patient-years (95% confidence interval [95% CI] 3.0-4.3). Among the 599 patients without a history of ACS, 66 incident ACS events occurred over 3,085 person-years, an incidence of 2.1 ACS events per 100 person-years (95% CI 1.7-2.7). The incidence of new ACS events per 100 patient-years was 1.1 (95% CI 0.6-1.7) among patients without plaque, 2.5 (95% CI 1.7-3.8) among patients with unilateral plaque, and 4.3 (95% CI 2.9-6.3) among patients with bilateral plaque. Covariates associated with incident ACS events independent of atherosclerosis included male sex, diabetes mellitus, and a cumulative glucocorticoid dose of ≥ 20 gm.
Conclusion:
Atherosclerosis is strongly associated with ACS in RA. RA patients with carotid plaque, multiple CV risk factors (particularly diabetes mellitus or hypertension), many swollen joints, and a high cumulative dose of glucocorticoids, as well as RA patients who are men, are at high risk of ACS.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures

